Navigation Links
AnaptysBio Selects Gable PR of San Diego for National Communications Program During Key Phase in Growth
Date:3/2/2009

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company seeking expanded outreach to the biotech and pharma industries, has selected Gable PR of San Diego to provide national public relations and investor communications programs as a key part of the company's strategic growth plan for 2009 and beyond.

San Diego, Calif. (PRWEB) March 2, 2009 -- AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced it has selected Gable PR to provide public relations and investor communications programs as a key part of the company's strategic growth plan for 2009 and beyond. Gable PR is a growing public relations firm based in San Diego and known for its sophisticated and successful approach to managing complex programs for national biotech companies and organizations.

"Gable PR will play a vital role in helping us communicate with key audiences about the advantages of our platform for antibody discovery," said Tom Smart, AnaptysBio chairman and CEO. "We selected Gable PR because of their past successes helping biotech companies with complex messages reach out to broader industry audiences. We anticipate achieving several important milestones in 2009 in validating our platform and need an agency partner that can take charge of getting out the word in a very targeted way to potential partners and investors."

AnaptysBio has developed a platform for generating therapeutic antibodies that is unique in the field. The platform mimics the body's natural evolution and selection processes for creating potent antibodies to fight disease. As a result, AnaptysBio believes the antibodies generated by its platform will result in therapies that are highly effective and better tolerated by the human body. Competing platforms often require scientists make artificial changes to antibodies, resulting in lower likelihood that they will be well tolerated.

"In checking out competing companies, we were impressed with the clear advantages AnaptsyBio demonstrated with the quality of its team, technology and culture," said Tom Gable, CEO of Gable PR. "They have a clear vision to 2010 and beyond and we're pleased to have been selected to help them reach key partners and potential investors with their story and data."

AnaptysBio's public relations program will be managed by Erin Koch, Gable PR director. The agency team includes professionals with significant investor relations, media relations, and media training experience.

About AnaptysBio:
Founded in 2005, AnaptysBio, Inc is a privately-held therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease. The Company's SHM-Platform™ utilizes the key components of SHM and other techniques to generate antibodies for therapeutic applications through an iterative process of natural evolution and high-throughput selection - a process that has been referred to as "naturalizing" antibodies. This versatile platform can be used both to discover and optimize antibodies directed at specific disease targets and also affinity mature existing antibodies to improve their binding properties. The company has established broad intellectual property around the use of SHM for therapeutic antibody applications, and is currently building a pipeline of novel therapeutic antibody product candidates. For more information, visit www.anaptysbio.com.

About Gable PR:
Gable PR, based in San Diego, delivers highly effective public relations and marketing communications programs for clients in a broad range of industries. Its tradition of success goes back 30 years with Tom Gable, APR, PRSA Fellow and a nationally recognized authority on the strategic use of public relations for positioning, reputation management and delivering meaningful results. Clients have included private and public companies, organizations, institutions and government agencies at every stage in their life cycles, from start-up to a Fortune 100 company (Pfizer). Agency programs have earned the highest honors in the PR profession and helped clients of all sizes and needs succeed. For more information: www.gablepr.com.

###

Read the full story at http://www.prweb.com/releases/2009/03/prweb2195614.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
2. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
3. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
4. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
5. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
6. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
7. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
8. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
9. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
10. Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal
11. Fallon Community Health Plan Selects CaseNET to Enhance Care Services Infrastructure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to change Medicare health ... is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their ... D) need to make changes during this period order for their new policy to ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... Beverly Hills, California, will be included in the 2016 “Guide to America’s Top ... professionals based on the amalgamation of their education, experience, and professional associations. ...
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd Regional ... Resort and Spa in Honolulu, offering local frontline clinicians the opportunity to extend ... , The demand for supplemental training related to pain management has surged dramatically ...
(Date:12/2/2016)... ... 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, Texas, ... Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in 1934 ... details line up exactly with Bible Prophecy – a protected way for those who ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Extremity Braces & Support) is Expected to Gain a Significant ... Prone to Orthopedic Ailments  ... , , According ... Market Study on Medical Implants Sterile Packaging: Clamshell Product Type ...
(Date:12/2/2016)... 2016   CytoSorbents Corporation (NASDAQ: CTSO ... Union approved CytoSorb ® cytokine adsorber to treat ... announced that Dr. Phillip Chan , Chief Executive ... Micro Main Event investor conference held from December ... Sunset Boulevard Hotel in Los Angeles, California ...
(Date:12/2/2016)... , December 2, 2016 On Thursday, ... 1.36%; the Dow Jones Industrial Average edged 0.36% higher, to ... down 0.35%. Losses were broad based as six out of ... initiated research reports on the following Services equities: Myriad Genetics ... QGEN ), INC Research Holdings Inc. (NASDAQ: ...
Breaking Medicine Technology: